Ortin Global shareholders approve director reappointments and MD change

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • All five resolutions passed with 99.99% votes in favor
  • Prashant Prakash Sawant appointed as Managing Director
  • Murali Krishna Murthy Sanka moved to Non-Executive Director
  • Parveen Satija appointed as Whole-Time Director
  • 55 members voted on ordinary resolutions; 54 on special ones
powered bylight_fuzz_icon
52408427

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited shareholders approved all five resolutions proposed at the 39th Annual General Meeting (AGM) held on September 30, 2026. The meeting, conducted via video conferencing, saw overwhelming support for financial adoption and significant governance changes.

The resolutions included the adoption of audited financial statements for FY26 and several appointments. Notably, Mr. Prashant Prakash Sawant was appointed as Managing Director, replacing his role as Whole-Time Director. Simultaneously, Mr. Murali Krishna Murthy Sanka’s designation changed from Managing Director to Non-Executive Director.

Voting results and participation

The e-voting process was scrutinized by Vivek Surana & Associates. A total of 55 members voted on most resolutions, representing 501,887 votes. For the special resolutions regarding director designations, 54 members voted, casting 289,046 votes. The low number of dissenting votes (48 against) indicates strong shareholder alignment with the board's proposals.

Resolution Type Votes in Favor (%) Votes Against (%) Status
Adoption of Financial Statements Ordinary 99.99 0.01 Passed
Re-appointment of Murali Krishna Murthy Sanka Ordinary 99.99 0.01 Passed
Designation change: Sanka to Non-Executive Special 99.99 0.01 Passed
Designation change: Sawant to MD Special 99.99 0.01 Passed
Appointment of Parveen Satija as WTD Special 99.99 0.01 Passed

Governance shifts

The AGM formalized a shift in executive leadership. Mr. Prashant Prakash Sawant, previously serving as Whole-Time Director, now assumes the role of Managing Director. This change follows the transition of Mr. Murali Krishna Murthy Sanka from Managing Director to Non-Executive Director. Additionally, Mr. Parveen Satija was appointed as a Director and Whole-Time Director, expanding the board's executive capabilities.

What the numbers show

The voting data reveals a distinct pattern in shareholder engagement based on resolution type. While ordinary resolutions attracted 55 members and over 5 lakh votes, the special resolutions concerning director designations saw slightly lower participation with 54 members and approximately 2.89 lakh votes. The consistent 99.99% approval rate across all items suggests minimal opposition to the proposed governance changes, despite the promoter group holding a significant stake that voted unanimously in favor.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+1.40%-3.84%-2.75%+7.08%+27.15%-46.12%

How might the leadership transition from Mr. Sanka to Mr. Sawant influence Ortin Global's strategic direction and capital allocation priorities in FY27?

What specific operational synergies or expansion plans are expected from the appointment of Mr. Parveen Satija as Whole-Time Director?

Will the shift of Mr. Sanka to a Non-Executive Director role lead to changes in board oversight mechanisms or risk management protocols?

Ortin Global closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours post-results declaration
  • Applies to Q2FY27 and H1FY27 financial results
  • Complies with SEBI insider trading regulations
powered bylight_fuzz_icon
51619900

*this image is generated using AI for illustrative purposes only.

Ortin Global Limited has closed its trading window for securities dealing effective October 1, 2026. The closure will remain in force until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

This action is taken pursuant to the company's Code of Conduct for Prevention of Insider Trading, adopted under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction applies to all designated persons, their immediate relatives, and connected persons covered under the code.

Board meeting scheduled for financial review

The Board of Directors will convene to consider and approve the unaudited financial results for the period ending September 30, 2026. A separate intimation regarding the notice of this board meeting will be sent to the stock exchanges.

Designated persons have been instructed not to trade in the company's securities during the specified closure period. This measure ensures compliance with regulatory standards regarding price-sensitive information.

Compliance details

Detail Information
Trading Window Closure Start October 1, 2026
Closure End 48 hours after results declaration
Reporting Period Quarter and half-year ended September 30, 2026
Regulatory Framework SEBI (Prohibition of Insider Trading) Regulations, 2015
Signed By Prashant Prakash Sawant, Managing Director

The filing was signed by Prashant Prakash Sawant, Managing Director, on September 22, 2026. The registered office is located in Hyderabad, Telangana.

Historical Stock Returns for Ortin Global

1 Day5 Days1 Month6 Months1 Year5 Years
+1.40%-3.84%-2.75%+7.08%+27.15%-46.12%

How might the upcoming Q2 FY27 financial results influence Ortin Global's stock volatility once the trading window reopens?

What are the potential impacts of Ortin Global's half-year performance on its future capital expenditure plans or dividend announcements?

How does this trading window closure align with broader sector trends regarding pharmaceutical companies' quarterly earnings guidance in India?

More News on Ortin Global

1 Year Returns:+27.15%